Angle Share Price (AGL)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Angle Plc	LSE:AGL	London	Ordinary Share	GB0034330679	ORD 10P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	+0.00p	+0.00%	44.00p	43.00p	45.00p	44.00p	44.00p	44.00p	87,078	07:56:29

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Support Services	0.5	-7.4	-8.7	-	32.92

Related Shares
Experian (EXPN), Worldpay (WPG), PHSC Plc (PHSC), Alpha Returns (ARGP)

Angle (AGL) Latest News

Angle News

Date	Time	Source	Headline
27/7/2017	14:07	ALNC	ANGLE Sees Annual Loss Swell After Investing In Parsortix
27/7/2017	07:53	ALNCF	Alliance News Flash Headline
27/7/2017	07:03	UKREG	Angle PLC Preliminary Results
20/7/2017	13:18	ALNC	ANGLE Notes Cancer Study Presentation On Use Of Parsotix Platform
20/7/2017	13:00	BW	Preclinical Study Using Parsortix Presented at Tumor Models Boston Summit
20/7/2017	13:00	RNSNON	Angle PLC Preclinical Study Presented At Tumor Boston Summit
06/7/2017	10:05	UKREG	Angle PLC Notice of Results
04/7/2017	11:09	ALNC	ANGLE Says Headline Ovarian Cancer Study Data Supports Parsortix
04/7/2017	07:00	UKREG	Angle PLC Successful Headline Data in Ovarian Cancer Studies
15/6/2017	11:00	ALNC	ANGLE's Parsortix Test Discovers Rare Cell Linked To Prostate Cancer

More Angle News

Angle Takeover Rumours

Angle (AGL) Share Charts

1 Year Angle Chart

1 Month Angle Chart

Intraday Angle Chart

Angle (AGL) Discussions and Chat

Angle Forums and Chat

Date	Time	Title	Posts
20/8/2017	12:27	ANGLE 2016 – LIQUID BIOPSY TAKEOVER TARGET	7,282
16/3/2017	20:00	ANGLE [12.75p] TARA*S SHARE OF THE DECADE "TARGET PRICE Ј100.00 PER SHARE."	3,646
08/10/2016	12:43	Angle PLC 2011	30,115
02/12/2015	13:04	Angle 2016 – Liquid Biopsy Takeover Target	-
11/6/2015	08:16	MrKeysersoze	39

Add a New Thread

Angle (AGL) Most Recent Trades

No Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type

View all Angle trades in real-time

Angle (AGL) Top Chat Posts

Date	Subject
20/8/2017 09:20	Angle Daily Update: Angle Plc is listed in the Support Services sector of the London Stock Exchange with ticker AGL. The last closing price for Angle was 44p. Angle Plc has a 4 week average price of 41.25p and a 12 week average price of 41.25p. The 1 year high share price is 80p while the 1 year low share price is currently 41.25p. There are currently 74,815,774 shares in issue and the average daily traded volume is 45,482 shares. The market capitalisation of Angle Plc is £32,918,940.56. Read Full Thread Reply
01/8/2017 16:52	glasswala: It's frustrating to see the share price get smashed after the results of the trials. This is mainly the management's fault in not addressing the funding impasse as well as managing expectations. We all know that they require funds for further trials and Working Capital and it would have been better to have raised this when the share price was in the 70's but I think the results of trials were not as they had hoped and that's why they was no fund raising going as there was nothing to get the investing community interested in making an investment. The FDA submissions are further delayed and there was no enthusiasm in respect of additional machine or cassette sales. All an all a disappointing 6month with additional losses. Management is too top heavy and costs needs to be controlled especially management remuneration which are far too excessive for the set up. Read Full Thread Follow Reply
28/7/2017 09:01	life guard: Problem we have is loads of potential but low on sales. I thought pod cast was poor nothing we did not know.. The treated AN promised has occurred but the wrong way. Results promised for breast canctnow put back 6 months Now funds need replenishing and share price falling Finally there is talk of partnership which if can occur will be great No funding mentioned yet which o am surprised about it goes against the grain.. My hope is there is some unexpected news that boosts the share price and that is what AN is waiting for This is a high possibility with all the potential Parsortix has to offer. I am depressed the value of this co has fallen however I know that Parsortix will with its medical uniqness will succeed this may be with or without AN..so I calmly wait without concern of my investment. Read Full Thread Follow Reply
14/6/2017 13:01	maddox: Having invested in the biotech sector over the years - I have never previously seen such outstandingly good trial results as AGL has produced. However, IMHO this is not reflected in the share price and I don't think more good results will have a markedly different market response. It is commercialization news that we need to move the share price out of its current range. Regards Maddox Read Full Thread Follow Reply
11/6/2017 15:55	alloa2003: Personally I think if AGL had taken this slowly slowly approach a couple of years ago the share price would be much higher. We have suffered from mismanagement of expectations but hopefully the BOD have learnt a lesson. Let the results come through and let them speak for themselves. Trying to guess when the FDA might act on AGL's application(s) is a waste of time but good trial results will put more pressure on the FDA. Share price targets of £5 are unrealistic at this moment in time but we could have a game changing year and a rejuvenated share price. First of all we need to see constant positive news flow and better management of expectations. The recent research note suggesting a share price of 187p (from memory) seems ambitious but achievable in this very volatile area in which AGL operates. One of the other keys is to maximise the current benefits of Parsortix over competing system asap - that way we get a foothold in the market. Once we are there, the companies who operate in this area will not be changing their systems every 2 minutes and only then will we see the sales flow that everyone has been hoping for. Read Full Thread Follow Reply
30/3/2017 09:20	alloa2003: Personally I think we will get there in the end but I have to laugh when people ignore what the market is telling us with the share price. If the shares were £1.20 everyone would be saying the price reflects the potential but some how when the shares are 44p the market has got it all wrong. Short term weakness in the share price should spur the management to getting more focused. This is not just any old product this is a life saver if we put aside the potential for the share price for one moment, this can save lives. Read Full Thread Follow Reply
22/1/2017 21:05	fraybentos2: what is fair value for agl tiny revenues many competitors board of directors underperforming ctcs will not in the long term be used for cancer detection there is no proof of the value of ctcs for any other purpose no fda approval this year machine not fully automated delays in trials starting further dilution required absent deal lack of market confidence given revenues slow prospects and the above difficulties £10m perhaps on a good day so without a deal or pumped share price agl is worthless dilution required will be too high to make investable good news for mug punters the share price is higher than it should be bad news for mug punters the share price is falling Read Full Thread Follow Reply
20/12/2016 18:51	adorling: At least those greedy Directors will need to get the share price to 129p before they can exercise those options granted in November! "The exercise price for the new share options is 64.50 pence per share, representing the Company's closing mid-market share price on 25 November 2016, being the latest practicable date prior to this announcement. The options are subject to service and/or performance conditions. The new share options granted to the executive directors have a term of ten years and are subject to the performance condition that the share price has risen by at least 100% from the share price when the option is issued." Read Full Thread Follow Reply
10/12/2016 18:23	m5: Elbillo8 Dec '16 - 20:33 - 4518 of 4553 No disrespect, ignoring a share price because you have faith in the Company can be a dangerous game IMHO. Are you saying that if the share price dropped to 30p you would be still comfortable? It is rare that the market gets it consistently wrong. At the end of the day the only thing that does matter is the share price I do not see anything with the share price at the moment that causes concern as the share price is trading within its range, however should it move outside of that range I would be paying attention, that applies to both the upper and lower levels. I would say flexibility in any share is the key, if you sell you can always buy back. I wish all holders the best of luck. Read Full Thread Follow Reply
28/11/2016 07:17	gary38: Angle PLC ISSUE OF SHARE OPTIONSSource: UK Regulatory (RNS & others)TIDMAGLRNS Number : 2366QAngle PLC28 November 2016 For immediate release 28 November 2016 ANGLE plc("ANGLE" or the "Company")ISSUE OF SHARE OPTIONSANGLE plc (AIM: AGL; OTCQX: ANPCY), the specialist medtech company, announces that under the shareholder approved Remuneration Policy the Remuneration Committee has approved the issue of 1,500,000 share options to the Company's executive directors. The Remuneration Committee has also approved the issue of 1,805,000 share options to certain staff.Following the issue of these share options, the Company will have outstanding options over a total of 10,365,806 ordinary shares of GBP0.10, representing approximately 11.6% of its issued and to be issued share capital. This leaves approximately 3.9 million options unallocated within the approved limit of up to 16% of the issued and to be issued share capital from time to time.The exercise price for the new share options is 64.50 pence per share, representing the Company's closing mid-market share price on 25 November 2016, being the latest practicable date prior to this announcement. The options are subject to service and/or performance conditions.The new share options granted to the executive directors have a term of ten years and are subject to the performance condition that the share price has risen by at least 100% from the share price when the option is issued.Following the issue of the new share options, the total number of share options held by the executive directors of the Company will be: Read Full Thread Follow Reply
04/11/2016 00:42	escapetohome: Perhaps how netsci performs tomorrow on the fda news and the other news CE MARK will give somewhat of a tiny flavour of what agl share price will do on fda news. I know netsci not full fda , thts why i said small flavour ! Read Full Thread Follow Reply

Angle share price data is direct from the London Stock Exchange

Your Recent History

LSE

GKP

Gulf Keyst..

LSE

QPP

Quindell

FTSE

UKX

FTSE 100

LSE

IOF

Iofina

GBPUSD

UK Sterlin..

Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P:31 V: D:20170821 04:36:56